Soligenix (NASDAQ: SNGX) CEO Interview

Soligenix (NASDAQ: SNGX) CEO Interview

2018-02-07    12'44''

主播: Analyzer

11 0

介绍:
Significant NIH Funding and Two Pivotal Phase 3 Trials Ongoing